SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-129381
Filing Date
2019-04-30
Accepted
2019-04-30 16:16:57
Documents
19
Period of Report
2019-06-25
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d685689ddef14a.htm DEF 14A 616291
2 GRAPHIC g685689g12w55.jpg GRAPHIC 3095
3 GRAPHIC g685689g25v92.jpg GRAPHIC 99567
4 GRAPHIC g685689g40b71.jpg GRAPHIC 6303
5 GRAPHIC g685689g57t15.jpg GRAPHIC 27674
6 GRAPHIC g685689g59a14.jpg GRAPHIC 1252
7 GRAPHIC g685689g72q07.jpg GRAPHIC 3106
8 GRAPHIC g685689g88b19.jpg GRAPHIC 10691
9 GRAPHIC g685689pp1.jpg GRAPHIC 24344
10 GRAPHIC g685689pp10.jpg GRAPHIC 4531
11 GRAPHIC g685689pp11.jpg GRAPHIC 14457
12 GRAPHIC g685689pp12.jpg GRAPHIC 4625
13 GRAPHIC g685689pp2.jpg GRAPHIC 22026
14 GRAPHIC g685689pp3.jpg GRAPHIC 4715
15 GRAPHIC g685689pp4.jpg GRAPHIC 5907
16 GRAPHIC g685689pp5.jpg GRAPHIC 4584
17 GRAPHIC g685689pp6.jpg GRAPHIC 5310
18 GRAPHIC g685689pp7.jpg GRAPHIC 21508
19 GRAPHIC g685689pp8.jpg GRAPHIC 16338
  Complete submission text file 0001193125-19-129381.txt   1004412
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36274 | Film No.: 19781963
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences